At the start of the second day of the meeting, 9 Lyme disease advocates and patients called in to provide public comments. Their input was invaluable and helped committee members appreciate issues of concern throughout the country.
This section contains information from the three branches of the federal government: Executive, Legislative, and Judicial. The Lyme Disease Association, Inc. (LDA) has been instrumental for decades in playing a leadership roll in shaping government actions and public policy concerning Lyme and tick-borne diseases.
The Lyme Disease Association Inc. (LDA) feels it is imperative that the Lyme Community and the public understand the continued resistance by government agencies to provide information pertaining to chronic […]
The FY20 Tick-Borne Disease Research Program (TBDRP) Program Announcements managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP) are now posted to the grants.gov […]
Rep. Chris Smith Rep. Collin Peterson ISSUE At this time the Lyme Disease Association, Inc. is asking you to contact your Congress Member to ask him/her to sign on to […]
The White House released the Fiscal Year 2021 budget proposal which includes a $14 million increase compared to the 2020 enacted level that focuses on tick-borne diseases. Excerpts from Budget […]
The FY20 Tick-Borne Disease Research Program (TBDRP) Program managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP) has issued a preannouncement for the FY20 […]
The Centers for Disease Control (CDC) updated its website to include information regarding maternal-fetal transmission of Lyme disease. According to the CDC, “Untreated Lyme disease during pregnancy can lead to infection of the placenta. Spread from mother to fetus is possible but rare. Fortunately, with appropriate antibiotic treatment, there is no increased risk of adverse birth outcomes.”